The future of immune checkpoint cancer therapy after PD-1 and CTLA-4
Author:
Affiliation:
1. Department of Internal Medicine, University of Utah, Salt Lake City, UT, 84112 USA
2. Department of Oncology, City of Hope Cancer Center, Duarte, CA, 91010 USA
3. Department of Oncology, Huntsman Cancer Institute, Salt Lake City, UT, 84112 USA
Abstract
Publisher
Future Medicine Ltd
Subject
Oncology,Immunology,Immunology and Allergy
Link
https://www.futuremedicine.com/doi/pdf/10.2217/imt-2017-0024
Reference115 articles.
1. Cancer immunoediting: from immunosurveillance to tumor escape
2. Expression of tumour-specific antigens underlies cancer immunoediting
3. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
4. Hallmarks of Cancer: The Next Generation
5. Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Cited by 92 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Med23 deficiency reprograms the tumor microenvironment to promote lung tumorigenesis;British Journal of Cancer;2024-01-09
2. Pre-Clinical Investigations of the Pharmacodynamics of Immunogenic Smart Radiotherapy Biomaterials (iSRB);Pharmaceutics;2023-12-14
3. Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamily;2023-12-12
4. Nectin-4 has emerged as a compelling target for breast cancer;European Journal of Pharmacology;2023-12
5. The Influence of Obesity on Outcomes with Immune Checkpoint Blockade: Clinical Evidence and Potential Biological Mechanisms;Cells;2023-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3